Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | %Female (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Medicinal Chemistry | journal | 1.699 Q1 | 202 | 430 | 828 | 53487 | 4696 | 823 | 5.48 | 124.39 | 38.00 | |
2 | Current Molecular Pharmacology | journal | 1.689 Q1 | 49 | 18 | 64 | 2266 | 315 | 64 | 5.34 | 125.89 | 36.23 | |
3 | Current Cancer Drug Targets | journal | 2.137 Q1 | 103 | 94 | 232 | 8928 | 1118 | 220 | 4.78 | 94.98 | 36.19 | |
4 | Current Gene Therapy | journal | 1.347 Q2 | 80 | 50 | 132 | 6077 | 671 | 123 | 3.90 | 121.54 | 35.43 | |
5 | Current Drug Targets | journal | 1.461 Q1 | 119 | 193 | 419 | 21891 | 1600 | 379 | 3.72 | 113.42 | 35.54 | |
6 | Current Organic Synthesis | journal | 1.898 Q1 | 55 | 54 | 76 | 6660 | 304 | 73 | 3.57 | 123.33 | 30.71 | |
7 | Open Medicinal Chemistry Journal | journal | 0.921 Q2 | 23 | 13 | 7 | 776 | 25 | 6 | 3.57 | 59.69 | 56.00 | |
8 | Current Diabetes Reviews | journal | 1.103 Q2 | 68 | 49 | 117 | 4371 | 428 | 115 | 3.54 | 89.20 | 36.81 | |
9 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.997 Q2 | 52 | 33 | 70 | 4134 | 212 | 70 | 3.40 | 125.27 | 44.66 | |
10 | Current Proteomics | journal | 0.246 Q4 | 27 | 31 | 83 | 2471 | 216 | 80 | 3.27 | 79.71 | 32.39 | |
11 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.341 Q2 | 108 | 114 | 262 | 10207 | 950 | 234 | 3.16 | 89.54 | 33.73 | |
12 | Current Protein and Peptide Science | journal | 1.489 Q1 | 96 | 76 | 170 | 7147 | 626 | 156 | 2.96 | 94.04 | 39.73 | |
13 | Current Genomics | journal | 1.332 Q2 | 77 | 60 | 182 | 5679 | 574 | 178 | 2.85 | 94.65 | 40.78 | |
14 | Mini-Reviews in Medicinal Chemistry | journal | 0.855 | 107 | 108 | 395 | 10227 | 1177 | 393 | 2.84 | 94.69 | 37.46 | |
15 | Current Aging Science | journal | 0.694 Q2 | 42 | 29 | 80 | 2904 | 201 | 78 | 2.70 | 100.14 | 40.48 | |
16 | Recent Patents on Biotechnology | journal | 0.569 Q2 | 42 | 17 | 65 | 2277 | 159 | 64 | 2.69 | 133.94 | 37.10 | |
17 | Infectious Disorders - Drug Targets | journal | 0.778 Q3 | 61 | 48 | 131 | 4761 | 341 | 115 | 2.68 | 99.19 | 30.65 | |
18 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.615 Q3 | 39 | 34 | 96 | 3225 | 195 | 90 | 2.65 | 94.85 | 41.18 | |
19 | Current Chemical Biology | journal | 0.483 Q3 | 26 | 25 | 80 | 1798 | 131 | 79 | 1.96 | 71.92 | 33.33 | |
20 | Current Nanoscience | journal | 0.582 Q2 | 52 | 135 | 212 | 6698 | 464 | 212 | 1.94 | 49.61 | 30.43 | |
21 | Current Computer-Aided Drug Design | journal | 0.531 Q3 | 32 | 32 | 74 | 2728 | 163 | 70 | 1.91 | 85.25 | 31.40 | |
22 | Current Pharmacogenomics and Personalized Medicine | journal | 0.291 Q4 | 20 | 30 | 85 | 2789 | 112 | 75 | 1.61 | 92.97 | 41.79 | |
23 | Current Pharmaceutical Analysis | journal | 0.417 Q3 | 27 | 37 | 86 | 1517 | 111 | 85 | 1.29 | 41.00 | 42.28 | |
24 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.497 Q3 | 45 | 18 | 97 | 1059 | 156 | 93 | 1.22 | 58.83 | 47.46 | |
25 | Current Bioinformatics | journal | 0.415 Q3 | 38 | 38 | 66 | 3819 | 80 | 66 | 1.10 | 100.50 | 29.29 | |
26 | Drug Metabolism Letters | journal | 0.395 Q3 | 31 | 37 | 123 | 1126 | 151 | 121 | 1.05 | 30.43 | 32.52 | |
27 | Letters in Drug Design and Discovery | journal | 0.285 Q4 | 37 | 132 | 298 | 3642 | 274 | 298 | 0.94 | 27.59 | 33.46 | |
28 | Letters in Organic Chemistry | journal | 0.365 Q3 | 33 | 143 | 388 | 4119 | 347 | 388 | 0.92 | 28.80 | 33.59 | |
29 | Current Signal Transduction Therapy | journal | 0.268 Q4 | 22 | 48 | 69 | 4214 | 56 | 66 | 0.81 | 87.79 | 26.81 | |
30 | Open Biomarkers Journal | journal | 0.236 Q3 | 7 | 4 | 7 | 83 | 5 | 7 | 0.71 | 20.75 | 28.57 | |
31 | Current Enzyme Inhibition | journal | 0.183 Q4 | 19 | 25 | 63 | 2002 | 28 | 61 | 0.49 | 80.08 | 39.47 | |
32 | Open Biotechnology Journal | journal | 0.121 Q4 | 18 | 5 | 14 | 134 | 6 | 14 | 0.43 | 26.80 | 26.09 | |
33 | Current Cancer Therapy Reviews | journal | 0.143 Q4 | 17 | 28 | 104 | 3131 | 34 | 102 | 0.35 | 111.82 | 35.44 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®